{"blog": [], "keywords": [{"value": "AbbVie Inc", "name": "organizations", "rank": "1", "is_major": "N"}, {"value": "Stemcentrx Inc", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Stem Cells", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Cancer", "name": "subject", "rank": "5", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/04/29/business/dealbook/abbvie-to-buy-cancer-treatment-start-up.html", "document_type": "article", "byline": {"person": [{"middlename": "J.", "firstname": "Michael", "role": "reported", "rank": 1, "lastname": "de la MERCED", "organization": ""}, {"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 2}], "original": "By MICHAEL J. de la MERCED and ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-thumbWide.jpg", "legacy": {"wide": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/29/business/29DB-ABBVIE/29DB-ABBVIE-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "992", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "AbbVie agreed to pay $5.8 billion to acquire Stemcentrx as it continues its big push into cancer treatment.", "pub_date": "2016-04-29T00:00:00Z", "news_desk": "Business", "headline": {"main": "AbbVie to Buy Cancer Treatment Start-Up"}, "print_page": null, "snippet": "AbbVie agreed to pay $5.8 billion to acquire Stemcentrx as it continues its big push into cancer treatment.", "_id": "5722119938f0d83acb9a655e", "slideshow_credits": null, "abstract": null}